These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].
    Author: Baba S, Oji Y, Teramoto M, Kawabata K, Saito A.
    Journal: Gan To Kagaku Ryoho; 2009 Nov; 36(11):1905-6. PubMed ID: 19920398.
    Abstract:
    A 44-year-old female with premenopausal advanced breast cancer had been treated with a combination of LH-RH analogue and tamoxifen as primary endocrine therapy following adjuvant chemotherapy. Forty-seven months after operation, because metastases of contralateral axillary lymph nodes were detected by computer tomography, she was treated with a combination of LH-RH analogue and aromatase inhibitor as second-line endocrine therapy. During the 16-month administration of LH-RH analogue and aromatase inhibitor, she was been well without new metastatic lesions and maintained a high quality of life.
    [Abstract] [Full Text] [Related] [New Search]